Maxim A. Polygalov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maxim A. Polygalov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Irina B. Ivshina
Perm State University; Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences – branch of the Perm Federal Research Center, Ural Branch of the Russian Academy of Sciences
2 shared publications - Andrey L. Mulyukin
Winogradsky Institute of Microbiology, Research Center of Biotechnology, Russian Academy of Sciences, 60 let Oktyabrya, 7, bld. 2, 117312 Moscow, Russia
1 shared publication - Elena A. Tyumina
Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia
1 shared publication - Grigory Bazhutin
Perm Federal Research Center Ural Branch Russian Academy of Sciences, 13a Lenin Street, 614990 Perm, Russia
1 shared publication - Maria Subbotina
Perm Federal Research Center Ural Branch Russian Academy of Sciences, 13a Lenin Street, 614990 Perm, Russia
1 shared publication - Semyon M. Tyan
Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Street., 614081 Perm, Russia
1 shared publication
Latest Publications
- Open Access
Ketoprofen Tolerance and Removal by Rhodococcus spp.
Bacteria of the genus Rhodococcus are degraders of various ecotoxicants, including pharmaceuticals, yet their activity against ketoprofen—a non-steroidal anti-inflammatory drug (NSAID) frequently detected in aquatic environments—remains poorly explored. To address this gap, we assessed the tolerance and removal of ketoprofen across Rhodococcus strains from the Regional Specialised Collection of Alkanotrophic Microorganisms (official acronym IEGM, WFCC number 285). All 175 strains tolerated ketoprofen at minimum inhibitory concentrations far above reported environmental levels. Two particularly resilient strains, R. erythropolis IEGM 712 and R. qingshengii IEGM 746, sustained growth in ketoprofen-supplemented medium. Transmission electron microscopy (TEM) examinations showed that most cells preserved structural integrity and morphology, while energy dispersive X-ray spectroscopy and elemental mapping showed maintenance of K+ homeostasis. Over 14 days of cultivation in the mineral medium with n-hexadecane, these two strains removed 40–58% of ketoprofen. Exposure to ketoprofen altered cellular morphometry and surface charge (ζ-potential) and led to the formation of by-products with a predicted lower ecotoxicity than the parent compound. These findings underscore the potential of Rhodococcus strains for the bioremediation of ketoprofen.
Open AccessKetoprofen Tolerance and Removal by Rhodococcus spp.
Bacteria of the genus Rhodococcus are degraders of various ecotoxicants, including pharmaceuticals, yet their activity against ketoprofen—a non-steroidal anti-inflammatory drug (NSAID) frequently detected in aquatic environments—remains poorly explored. To address this gap, we assessed the tolerance and removal of ketoprofen across Rhodococcus strains from the Regional Specialised Collection of Alkanotrophic Microorganisms (official acronym IEGM, WFCC number 285). All 175 strains tolerated ketoprofen at minimum inhibitory concentrations far above reported environmental levels. Two particularly resilient strains, R. erythropolis IEGM 712 and R. qingshengii IEGM 746, sustained growth in ketoprofen-supplemented medium. Transmission electron microscopy (TEM) examinations showed that most cells preserved structural integrity and morphology, while energy dispersive X-ray spectroscopy and elemental mapping showed maintenance of K+ homeostasis. Over 14 days of cultivation in the mineral medium with n-hexadecane, these two strains removed 40–58% of ketoprofen. Exposure to ketoprofen altered cellular morphometry and surface charge (ζ-potential) and led to the formation of by-products with a predicted lower ecotoxicity than the parent compound. These findings underscore the potential of Rhodococcus strains for the bioremediation of ketoprofen.
- Open Access
- 26 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1101
Cellular Modifications of Rhodococci Exposed to Separate and Combined Effects of Pharmaceutical Pollutants
Actinomycetes of the genus Rhodococcus (class Actinomycetia) are dominant dwellers of biotopes with anthropogenic load. They serve as a natural system of primary response to xenobiotics in open ecosystems, initiate defensive responses in the presence of pollutants, and are regarded as ideal agents capable of transforming and degrading pharmaceuticals. Here, the ability of selected Rhodococcus strains to co-metabolize nonsteroidal anti-inflammatory drugs (ibuprofen, meloxicam, and naproxen) and information on the protective mechanisms of rhodococci against toxic effects of pharmaceuticals, individually or in a mixture, have been demonstrated. For the first time, R. ruber IEGM 439 provided complete decomposition of 100 mg/L meloxicam after seven days. It was shown that versatile cellular modifications occurring at the early development stages of nonspecific reactions of Rhodococcus spp. in response to separate and combined effects of the tested pharmaceuticals included changes in electrokinetic characteristics and catalase activity; transition from unicellular to multicellular life forms accompanied by pronounced morphological abnormalities; changes in the average size of vegetative cells and surface area-to-volume ratio; and the formation of linked cell assemblages. The obtained data are considered as adaptation mechanisms in rhodococci, and consequently their increased resistance to separate and combined effects of ibuprofen, meloxicam, and naproxen.
- 26 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1101
Open AccessCellular Modifications of Rhodococci Exposed to Separate and Combined Effects of Pharmaceutical Pollutants
Actinomycetes of the genus Rhodococcus (class Actinomycetia) are dominant dwellers of biotopes with anthropogenic load. They serve as a natural system of primary response to xenobiotics in open ecosystems, initiate defensive responses in the presence of pollutants, and are regarded as ideal agents capable of transforming and degrading pharmaceuticals. Here, the ability of selected Rhodococcus strains to co-metabolize nonsteroidal anti-inflammatory drugs (ibuprofen, meloxicam, and naproxen) and information on the protective mechanisms of rhodococci against toxic effects of pharmaceuticals, individually or in a mixture, have been demonstrated. For the first time, R. ruber IEGM 439 provided complete decomposition of 100 mg/L meloxicam after seven days. It was shown that versatile cellular modifications occurring at the early development stages of nonspecific reactions of Rhodococcus spp. in response to separate and combined effects of the tested pharmaceuticals included changes in electrokinetic characteristics and catalase activity; transition from unicellular to multicellular life forms accompanied by pronounced morphological abnormalities; changes in the average size of vegetative cells and surface area-to-volume ratio; and the formation of linked cell assemblages. The obtained data are considered as adaptation mechanisms in rhodococci, and consequently their increased resistance to separate and combined effects of ibuprofen, meloxicam, and naproxen.